Gilead Sciences Ltd commissioned PHAST to undertake some research to inform the next steps in NASH and NAFLD Service Delivery. Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercialises innovative medicines in areas of unmet medical need. With each...Read more
The PHAST Christmas Associates meeting was held at the Kings Fund last week and we were delighted to announce guest speaker; Sir J.A Muir Gray CBE covering "The Future of Healthcare 2025".Sir Muir Gray is the Director of Better Value Healthcare, adviser to Public Health England and Chair of the...Read more
Speaking at the PHAST Associate Meeting on Thursday 17th September was Layth Hanbali National Director of Medsin who delivered the presentation you can view below. Read more
At the PHAST Associate meeting on Thursday 17th September, we were delighted to welcome our guest speaker Shirley Cramer CBE Chief Executive of RSPH.
You can view her presentation slides via the link below.Read more
PHAST are pleased to make available two presentations given at our PHAST friends and associates meeting in February. You can download them below.Read more